SCH 727965 in Patients With Mantle Cell Lymphoma or B-Cell Chronic Lymphocytic Leukemia (Study P04715)

Clinical trial NCT00871546 · TERMINATED

Trial details

NCT number: NCT00871546
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Mantle-Cell Leukemia, Lymphocytic, Chronic, B-Cell

Start date: 2009-03-01
Primary completion: 2010-12-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.